When combining TPP‐LND@Lip or PD‐L1 monoclonal antibody with radiotherapy, tumor growth was almost completely slowed down, with growth inhibition rates of 79.6 ± 5.2% and 64.2 ± 12.2% on day 14, respectively (Figure 8B,C and Figure S30, Supporting Information). This evidence concerns the gene CD274 and neoplasm.